Abstract
BackgroundPsoriasis is a chronic disease characterized by the development of scaly red skin lesions and possible co-morbid conditions. The psoriasis lesional skin transcriptome has been extensively investigated, but mRNA levels do not necessarily reflect protein abundance. The purpose of this study was therefore to compare differential expression patterns of mRNA and protein in psoriasis lesions.MethodsLesional (PP) and uninvolved (PN) skin samples from 14 patients were analyzed using high-throughput complementary DNA sequencing (RNA-seq) and liquid chromatography-tandem mass spectrometry (LC-MS/MS).ResultsWe identified 4122 differentially expressed genes (DEGs) along with 748 differentially expressed proteins (DEPs). Global shifts in mRNA were modestly correlated with changes in protein abundance (r = 0.40). We identified similar numbers of increased and decreased DEGs, but 4-fold more increased than decreased DEPs. Ribosomal subunit and translation proteins were elevated within lesions, without a corresponding shift in mRNA expression (RPL3, RPS8, RPL11). We identified 209 differentially expressed genes/proteins (DEGPs) with corresponding trends at the transcriptome and proteome levels. Most DEGPs were similarly altered in at least one other skin disease. Psoriasis-specific and non-specific DEGPs had distinct cytokine-response patterns, with only the former showing disproportionate induction by IL-17A in cultured keratinocytes.ConclusionsOur findings reveal global imbalance between the number of increased and decreased proteins in psoriasis lesions, consistent with heightened translation. This effect could not have been discerned from mRNA profiling data alone. High-confidence DEGPs were identified through transcriptome-proteome integration. By distinguishing between psoriasis-specific and non-specific DEGPs, our analysis uncovered new functional insights that would otherwise have been overlooked.Electronic supplementary materialThe online version of this article (doi:10.1186/s13073-015-0208-5) contains supplementary material, which is available to authorized users.
Highlights
Psoriasis is a chronic disease characterized by the development of scaly red skin lesions and possible co-morbid conditions
Psoriasis lesions develop as a consequence of abnormal keratinocyte (KC) proliferation, which may be driven by key pro-inflammatory cytokines, including tumor necrosis factor (TNF), interleukin (IL)-17A and IL-23 [3]
A subsequent study used 2D electrophoresis combined with liquid chromatography tandem mass spectrometry (LC-MS/MS) to identify 36 proteins elevated 2-fold in psoriasis lesions (e.g., GSTP1, SFN, PRDX2), which were functionally related to diverse processes, such as apoptosis, defense response, inflammatory response, redox balance and cell proliferation [20]
Summary
Psoriasis is a chronic disease characterized by the development of scaly red skin lesions and possible co-morbid conditions. Psoriasis lesions develop as a consequence of abnormal keratinocyte (KC) proliferation, which may be driven by key pro-inflammatory cytokines, including tumor necrosis factor (TNF), interleukin (IL)-17A and IL-23 [3] Such cytokines are manufactured by immune cells that infiltrate psoriasis lesions (e.g., T cells, macrophages and Swindell et al Genome Medicine (2015) 7:86 fully understand psoriasis from a systems biology standpoint. This can reduce false-positive identifications and extend transcriptome findings by identifying those differentially expressed mRNAs impacting protein abundance, which may be more consequential for the disease process [14, 15]. This trend appears to agree well with transcriptome studies, which have shown that genes differentially expressed in psoriasis lesions include a disproportionate number of IL-1B targets [8, 22]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.